ML25092A081
| ML25092A081 | |
| Person / Time | |
|---|---|
| Issue date: | 04/16/2025 |
| From: | Christopher Regan NRC/NMSS/DREFS |
| To: | Lattanze R Lucerno Dynamics |
| References | |
| NRC-2022-0218, RIN 3150-AK91, LTR-25-0120-1 | |
| Download: ML25092A081 (1) | |
Text
Ronald K. Lattanze Lucerno Dynamics, LLC 140 Towerview Court Cary, NC 27513 rlattanze@lucernodynamics.com
Dear Mr. Lattanze:
Thank you for your letter dated March 10, 2025, regarding your concerns over NRCs draft proposed rule on Reporting Nuclear Medicine Injection Extravasations as Medical Events. The draft proposed rule and associated guidance are part of the staff paper, SECY-24-0067 (ADAMS Accession No. ML24016A290), which is currently with the Commission for review and approval.
We will place your letter on the docket. Your concerns will be considered as we continue the rulemaking process, and, if the proposed rule is approved by the Commission, we strongly encourage you to submit your concerns in a comment on the proposed rule. Specific information about the rulemaking can be found at the NRC Reading Room and at https://www.regulations.gov under Docket ID NRC-2022-0218. We look forward to your continuing participation and engagement in our rulemaking process.
If you have any questions or need additional information, please contact the rulemaking project manager, Irene Wu, at Irene.Wu@nrc.gov.
Sincerely, Christopher Regan, Director Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards April 16, 2025 Signed by Regan, Christopher on 04/16/25
ML25092A081 (Letter) ML25092A082 (Incoming)
OFFICE NMSS/REFS/
MRPB NMSS/REFS/
MRPB NMSS/REFS OGC NMSS/REFS NAME IWu ACarrera MRalph for CRegan MSmith CRegan DATE 04/02/25 04/02/25 04/04/25 04/07/25 04/16/2025